Literature DB >> 2417412

Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses.

R Ray, R W Compans.   

Abstract

A panel of twenty monoclonal antibodies to the hemagglutinin-neuraminidase (HN) glycoprotein of human parainfluenza 3 (PI3) virus has been obtained and tentatively classified into four different groups based on reactivity in hemagglutination inhibition (HI), neuraminidase inhibition (NI), and plaque neutralization (NT) tests. The antibodies were tested for cross-reactivity with bovine PI3 virus, Sendai virus, and simian virus 5 (SV5). Only two of these antibodies showed similar reactivities with human and bovine PI3 viruses in HI and NT tests; a few other antibodies showed low levels of reactivity with the heterologous viruses in HI tests. A competitive binding assay further suggested that the two cross-reactive antibodies are directed against the same domain of the HN molecule. Therefore, the HN glycoproteins of human and bovine PI3 viruses appear to be antigenically dissimilar, although they share at least one common epitope.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417412     DOI: 10.1016/0042-6822(86)90420-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells.

Authors:  P G Hughey; R W Compans; S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus.

Authors:  S D Thompson; W G Laver; K G Murti; A Portner
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

3.  Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.

Authors:  K van Wyke Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.

Authors:  R Ray; K Meyer; F K Newman; R B Belshe
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 5.  Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview.

Authors:  Enrique Villar; Isabel Muñoz Barroso
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

6.  Nucleotide sequence of the bovine parainfluenza 3 virus genome: the genes of the F and HN glycoproteins.

Authors:  S Suzu; Y Sakai; T Shioda; H Shibuta
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

7.  Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces.

Authors:  Q Yao; X Hu; R W Compans
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity.

Authors:  R M Iorio; G M Field; J M Sauvron; A M Mirza; R Deng; P J Mahon; J P Langedijk
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene.

Authors:  R Ray; M S Galinski; B R Heminway; K Meyer; F K Newman; R B Belshe
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

Review 10.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.